» Articles » PMID: 20129022

Severe Renal Failure and Microangiopathic Hemolysis Induced by Malignant Hypertension--case Series and Review of Literature

Overview
Journal Clin Nephrol
Specialty Nephrology
Date 2010 Feb 5
PMID 20129022
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant nephrosclerosis is acute renal failure in the setting of malignant hypertension and may be associated with thrombotic microangiopathy. Although the prognosis has improved considerably over the past decades, renal dysfunction remains an important cause of morbidity and mortality. Adequate control of blood pressure is crucial, allows gradual healing of the necrotizing vascular lesions and may induce stabilization and improvement of renal function in about 50 - 80% of involved patients. In addition, recent investigations have provided a better understanding of the pathophysiology of malignant hypertension and offer possibilities for identifying patients at risk. We report 3 patients who developed severe acute renal failure requiring dialysis initiation in the setting of malignant hypertension. All patients had kidney biopsy proven malignant nephrosclerosis and presented with symptoms of thrombotic microangiopathy. Despite adequate blood pressure control the prognosis of our patients varied.

Citing Articles

Monoclonal Gammopathy of Renal Significance and Thrombotic Microangiopathy: A Case Report.

Ventura S, Cabral R, Viveiros C, Santos M, Esteves J Cureus. 2023; 14(12):e32753.

PMID: 36686103 PMC: 9851652. DOI: 10.7759/cureus.32753.


Thrombotic Microangiopathy Due to Malignant Hypertension Treated Exclusively With Antihypertensive Therapy.

Asano T, Mori H Cureus. 2022; 14(2):e21835.

PMID: 35291517 PMC: 8895853. DOI: 10.7759/cureus.21835.


Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study.

Haridasan S, Priyamvada P, Puthiyottil D, Pradeep A, Parameswaran S, Srinivas B Indian J Nephrol. 2021; 31(5):467-473.

PMID: 34880557 PMC: 8597798. DOI: 10.4103/ijn.IJN_187_20.


Malignant hypertension: does this still exist?.

Domek M, Gumprecht J, Lip G, Shantsila A J Hum Hypertens. 2019; 34(1):1-4.

PMID: 31636349 DOI: 10.1038/s41371-019-0267-y.


Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy.

Larsen C, Wilson J, Best-Rocha A, Beggs M, Hennigar R Mod Pathol. 2017; 31(3):488-494.

PMID: 29148534 PMC: 5843820. DOI: 10.1038/modpathol.2017.154.